Literature DB >> 10688600

M(2) and M(4) receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro.

P W Stengel1, J Gomeza, J Wess, M L Cohen.   

Abstract

Peripheral muscarinic receptors play key roles in the control of heart rate and smooth muscle activity. In this study, bradycardic and smooth muscle contractile responses to the muscarinic agonist carbamylcholine were compared in isolated tissues from M(2) and M(4) muscarinic receptor knockout mice and their wild-type littermates. Carbamylcholine (1 x 10(-8)-3 x 10(-5) M) produced similar concentration-dependent bradycardia in spontaneously beating atria from M(4) receptor knockout and wild-type control mice. In contrast, carbamylcholine did not produce bradycardia in atria derived from M(2) receptor knockout mice, whereas such atria were responsive to adenosine-induced bradycardia. Carbamylcholine-induced contractile responses were similar in stomach fundus, urinary bladder, and tracheal preparations from M(4) receptor knockout mice and their wild-type littermates for each tissue (-logEC(50) values ranging from 6.20 +/- 0.10 to 6.76 +/- 0.08), suggesting that M(4) receptors do not participate in smooth muscle contraction in these tissues. In contrast, approximately 2-fold higher carbamylcholine concentration was required for contraction of stomach fundus, urinary bladder, and trachea from M(2) receptor knockout mice (-logEC(50) = 6.39 +/- 0.05, 6.07 +/- 0.06, and 6.27 +/- 0.12, respectively) than from wild-type littermates (-logEC(50) = 6.68 +/- 0.07, 6.27 +/- 0.07, and 6.56 +/- 0.06, respectively). Furthermore, the affinity of the M(2) "selective" receptor antagonist AF-DX116 in inhibiting carbamylcholine-induced smooth muscle contraction was significantly reduced in M(2) receptor knockout mice compared with tissues from wild-type littermates. Collectively, these results provide direct and unambiguous evidence that M(2) receptors mediate muscarinic receptor-induced bradycardia and play a role in smooth muscle contractility, whereas M(4) receptors are not involved in stomach fundus, urinary bladder, or tracheal contractility.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688600

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  50 in total

1.  A multiplicity of muscarinic mechanisms: enough signaling pathways to take your breath away.

Authors:  N M Nathanson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D.

Authors:  G Hansen; S Jin; D T Umetsu; M Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 3.  Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system.

Authors:  Frank P Bymaster; David L McKinzie; Christian C Felder; Jürgen Wess
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 4.  Muscarinic receptors: what we know.

Authors:  Harriette M Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2003-12       Impact factor: 3.092

5.  Muscarinic receptors in isolated urinary bladder smooth muscle from different mouse strains.

Authors:  A Choppin
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

6.  Adrenomedullin upregulates M2-muscarinic receptors in cardiomyocytes from P19 cell line.

Authors:  Sophie Buys; Fatima Smih; Atul Pathak; Pierre Philip-Couderc; Patrick Verwaerde; Jean-Louis Montastruc; Philippe Rouet; Jean-Michel Senard
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 7.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 8.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

9.  An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins.

Authors:  Rajendra Mistry; Mark R Dowling; R A John Challiss
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

10.  Genetic disruption of G proteins, G(i2)alpha or G(o)alpha, does not abolish inotropic and chronotropic effects of stimulating muscarinic cholinoceptors in atrium.

Authors:  P Boknik; S Grote-Wessels; G Barteska; M Jiang; F U Müller; W Schmitz; J Neumann; L Birnbaumer
Journal:  Br J Pharmacol       Date:  2009-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.